Abstract Body

Background

The hepatitis B virus (HBV) is characterised by extensive genetic diversity, including low-frequency minority variants that contribute to disease progression. While these variants represent a critical component of the viral genome pool, their role is often underestimated due to limitations in detection. We therefore characterized low-frequency minority variants associated with drug resistance and immune escape mutations and evaluated their potential clinical impact.

Methods

We utilized 141 whole-genome sequences generated using next-generation sequencing from the Botswana Combination Prevention Project (BCPP) samples—the largest cohort in Botswana, with over 6,000 individuals screened for HBV to date—to analyze minority variants (<20%), using an enhanced in-house bioinformatics suite (HBVgenomer v5.9). These represent genotypes A1, D3, and E. We filtered for minority variants (1-20%), and the filtered variants were compared to previously published drug resistance and escape mutations at the consensus level (>20%). The differences in viral diversity and the dominance of escape variants by viral load (VL) categories (Detectable, target not detected (TND)) were compared using the Wilcoxon rank-sum test.

Results

Across 83 samples, a total of 516 minority variants were observed, corresponding to previously published mutations with suspected roles in viral escape. The A159T variant was the most frequent (n = 24). Shannon entropy correlated with the top-variant frequency (ρ = 0.86, p < 0.0001) in samples with known viral load, indicating that strongly dominant escape variants showed higher overall diversity. Including samples without VL slightly reduced the strength of the correlation (ρ = 0.76, p < 1.9 × 10⁻⁹), yet the relationship remained highly significant. When stratified by VL, samples with detectable VL had a median top variant frequency of 4.5% (IQR 3.1–11.2%), compared with 12.5% (IQR 8.2–16.7%) in TND samples (Wilcoxon W = 93, p = 0.00408)

Conclusions

We identified minority variants that have been previously suspected to have roles in viral escape, thus highlighting the importance of characterizing minority variants. Our findings show that detectable HBV VL is associated with higher diversity, with lower dominance of escape variants (4.5%), while TNDs , who in most studies are rarely sequenced, have reduced diversity but stronger dominance of single variants (12.5%). Minority escape variants are frequent, and HBV VL influences their distribution and dominance.